Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

59.47
BATS BZX Real-Time Price
As of 10:40am ET
 -0.49 / -0.82%
Today’s Change
35.41
Today|||52-Week Range
74.50
+39.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.5B

Company Description

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.

Contact Information

Ultragenyx Pharmaceutical, Inc.
60 Leveroni Court
Novato California 94949
P:(415) 483-8800
Investor Relations:
(415) 475-6876

Employees

Shareholders

Mutual fund holders80.54%
Other institutional19.10%
Individual stakeholders13.88%

Top Executives

There are no executives to display.